Patent · US Active

Compositions and methods for improving strand biased

US12173287B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 7, 2019
Grant dateDec 24, 2024
Priority date
Expiry dateOct 21, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

One aspect of the present invention relates to double-stranded RNA (dsRNA) agent capable of inhibiting the expression of a target gene. Other aspects of the invention relate to pharmaceutical compositions comprising these dsRNA molecules suitable for therapeutic use, and methods of inhibiting the expression of a target gene by administering these dsRNA molecules, e.g., for the treatment of various disease conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.